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Abstract
Using isolated, in situ, single-pass perfused rat livers, incuba-
tions of freshly isolated hepatocytes, and sinusoidal mem-
brane-enriched vesicles, we and others have shown the satura-
bility of transport (efflux) of hepatic glutathione (GSH). These
observations have implicated a carrier mechanism. Our
present studies were designed to provide further evidence in
support of a carrier mechanism for hepatic GSH efflux by
demonstrating competition by liver-specific ligands which are
taken up by hepatocytes. Perfusing livers with different sub-
stances, we found that: (a) sulfobromophthalein-GSH (BSP-
GSH) had a dose-dependent and fully reversible inhibitory
effect on GSH efflux, while GSH alone did not have any effect;
(b) taurocholate had no inhibitory effect; (c) all of the organic
anions studied, i.e., BSP, rose bengal, indocyanine green, and
unconjugated bilirubin (UCB), manifested potent, dose-depen-
dent inhibitory effects, with absence of toxic effects and com-
plete reversibility of inhibition in the case of UCB. The inhibi-
tory effects of UCB could be overcome partially by raising
(CoC12-induced) hepatic GSH concentration.
Because of the physiological importance of UCB, we con-
ducted a detailed study of its inhibitory kinetics in the isolated
hepatocyte model in the range of circulating concentrations of
UCB. Studies with Cl1-free media, to inhibit the uptake of
UCB by hepatocytes, showed that the inhibition ofGSH efflux
by UCB is apparently from inside the cell. This point was
confirmed by showing that the inhibition is overcome only
when bilirubin-loaded cells are cleared of bilirubin (incubation
with 5% bovine serum albumin). Using Gunn rat hepatocytes
and purified bilirubin mono- and diglucuronides, we found that
both UCB and glucuronide forms of bilirubin inhibit GSH ef-
flux in a dose-dependent manner. We conclude that the organic
anions, although taken up by a mechanism independent of
GSH, may competitively inhibit the carrier for GSH efflux
from inside the hepatocyte.
Introduction
Glutathione exists in high concentrations (5-7 mM) in the
liver, chiefly in the reduced form (GSH), and plays a major
role in many detoxification and regulatory processes (1). The
efflux ofGSH from the liver is estimated to account for nearly
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all of hepatic GSH turnover (2). Using the isolated, perfused
rat liver and freshly isolated hepatocyte systems, we have pre-
viously shown that sinusoidal efflux ofGSH is saturable and
thus, presumably, carrier mediated (3, 4). The saturability and
transstimulation of GSH transport have been shown in sinu-
soidal membrane-enriched vesicles (5, 6).
In our initial work (3), we had conducted some preliminary
experiments with sulfobromophthalein (BSP)'-GSH and had
found that it could inhibit GSH efflux from the perfused rat
liver. This outcome further supported the view that sinusoidal
effilux of GSH is carrier mediated. Since BSP-GSH is an or-
ganic anion, we have examined the effect on GSH transport of
several such molecules known to be taken up by hepatocytes.
To accomplish this aim, we used the isolated, in situ, perfused
rat liver system to screen organic anions (dyes), bilirubin, and
taurocholate to find out whether they have any inhibitory ef-
fect on the GSH efflux. Since, among the compounds that
exerted an inhibitory effect, bilirubin was the physiologically
relevant and important organic anion, we studied the kinetics
of its inhibitory effect on GSH efflux in more detail, using
freshly isolated hepatocyte incubations. We extended our in-
vestigations to delineate whether the inhibitory effect is ex-
erted from outside or inside the hepatocytes, as well as to
identify the molecular form(s) of bilirubin (i.e., unconjugated
vs. glucuronide forms) responsible for inhibition.
Methods
Chemicals and reagents. GSH, unconjugated bilirubin (UCB), colla-
genase (type IV), bovine serum albumin, organic anion dyes (BSP, rose
bengal, and indocyanine green) and Hepes were purchased from Sigma
Chemical Co. (St. Louis, MO). HPLC-grade methanol was purchased
from Fisher Scientific Co. (Springfield, NJ). All other materials used
were of analytic reagent grade and were obtained from commercial
sources.
Animals. Male Sprague-Dawley rats (Hilltop Laboratory Animals,
Inc., Scottdale, PA), 200-300 g, were maintained on Purina rodent
chow (Ralston Purina Co., St. Louis, MO) and water ad libitum. To
induce an increased hepatic GSH concentration, some rats received
CoCl2 injections as described previously (3). The cumulative doses
given in our present study were 80-100 mg of CoCl2/kg.
Male hetero- and homozygote Gunn rats, 300-450 g, used in our
studies were a generous gift of Dr. Anthony McDonagh of University
ofCalifornia, San Francisco, Liver Center. The distinct yellow color of
the sera and the HPLC analysis ofbile samples (see below), to establish
the absence ofbilirubin monoglucuronide (BMG) and bilirubin diglu-
curonide (BDG), were utilized as criteria for the acceptability of any
homozygote Gunn rat used in our studies.
Liver perfusions and hepatocyte incubations. The design, method,
and the apparatus described earlier (3) were used for our isolated, in
1. Abbreviations used in this paper: BMG and BDG, bilirubin mono-
and diglucuronide; BSP, sulfobromophthalein; ECF, extracellular
fluid; UCB, unconjugated bilirubin.
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situ perfusions. The perfusion rates using oxygenated Krebs-Ringer
bicarbonate buffer were 3.85±0.04 ml/min * g liver, perfusion pres-
sures were 5.5±0.3 cm H20, and the 02 uptakes were 2.13±0.03
,pmol/min * g liver (mean±SEM, n = 60-63). These values compare
very closely to those reported in our earlier studies (3). We had also
established that glutathione efflux from the perfused liver is virtually
all in the form of GSH, i.e., reduced glutathione (3). Perfusions with
Cl--free media were done with replacement of NaCl and KCl in the
Krebs-buffer with equimolar sucrose. In all cases, glutathione S-trans-
ferase was measured in the perfusates, as before (3), and found to
indicate no lysis.
Hepatocytes were isolated by the recirculating collagenase perfu-
sion method of Moldeus et al. (7), and handled as described earlier (4).
Cells were 2 93% viable at the onset of each incubation, as ascertained
by 0.2% trypan blue exclusion and quantitation of extracellular fluid
(ECF) glutathione S-transferase (4), a cytosolic enzyme marker. Incu-
bations were routinely carried out with 106 cells/ml (total initial vol-
ume = 10 ml). Our previous studies have established that practically all
of glutathione effluxing from isolated hepatocytes is in the form of
GSH. Additions of all compounds to be studied were made just before
the suspension of hepatocytes to the Krebs-Henseleit buffer, supple-
mented with 12.5 mM Hepes at pH 7.4 and 370C in 25-ml Erlenmeyer
flasks. Thereafter, at the onset of each incubation, washed hepatocytes
were suspended and rapidly dispersed in the incubation media. The
flasks containing cell suspensions were quickly returned to the heating
shaker bath. About 1-2 min was allowed for temperature equilibration
and settlement of any transient disturbances, after which the first sam-
ple was taken and expressed as t = 0 sample. Incubations were done
under room air with gentle shaking and periodic samples of cell sus-
pension (1 ml) were removed for immediate separation of cells and
ECF (5-s centrifugation on Beckman Instruments Microfuge) for sub-
sequent assays and analyses. Cell lysis was measured during the course
ofincubation by the measurement of released glutathione S-transferase
and the results were used to correct the ECF data for contributions
made by cytosolic contents due to lysis. The cumulative lysis through-
out our incubations generally remained well below 10%. Certain con-
trol incubations were carried out in the absence of hepatocytes (cell-
free incubations), or with hepatocytes but at < 4°C, as described in
Results. Cl--free incubations were done using an equimolar sucrose-
Hepes buffer. In incubations with UCB, BMG, and BDG, bovine
serum albumin was also added to the incubation media, just prior to
the addition of these compounds. The initial molar ratio of bilirubin
moieties to albumin was set at - 1. Detectable effects on the ECF
GSH were observable only at albumin concentrations . 0.5% (. 75
,uM). However, this effect is due to the promotion of mixed disulfide
formation in response to elevated albumin levels (unpublished obser-
vations). For our present studies, all incubations were done with
< 0.5% albumin.
After complete removal of the supernatants of centrifuged incuba-
tion samples, the cell pellets (106 cells) were ordinarily resuspended in
buffer (0.5 ml) and cellular GSH was extracted with addition of 10%
trichloroacetic acid (1:1, vol/vol), as described before (4). Whenever
cellular bilirubin measurements were required, the pellets were ex-
tracted with 0.5 ml of HPLC-grade methanol (Fisher Scientific Co.).
Our trials established that a single extraction step with 0.5 ml ofmetha-
nol could recover 80% of the total cellular unconjugated and glucuro-
nide forms of bilirubin that could be recovered with a total of four
successive extractions with methanol (levels of bilirubin in additional
washes fell below the detection levels of our methods). This one-step
extraction efficiency, i.e. 80%, was the same for the recovery ofcellular
GSH content by 0.5-ml methanol extraction, as compared to buffer
+ trichloroacetic acid extraction. Thus, in extractions of cell pellets
with methanol, we used a correction factor (multiplication by 1/0.8
= 1.25) to estimate the true cellular values, based on an 80% efficiency
of extraction.
In our studies, perfused livers from ad lib-fed rats of different
groups had average GSH concentrations in the typical range of 5-6
umol/g. Isolated hepatocytes averaged at - 40 nmol/106 cells or 4
Amol/g liver of GSH (108 cells = 1 g), except for the CoCl2-treated
group which reached an average value of -77mol/g. Mean±SEM for
each group is presented in the tables and the legends to the figures.
To measure the total glutathione S-transferase content of the cells
used in any incubation, additional samples of 106 pelleted cells were
resuspended in 0.5 ml of buffer and digested with 10% triton X-100
(1:1, vol/vol). All resuspended pellets treated with trichloroacetic acid,
methanol, or Triton X-100 were again centrifuged in a Microfuge and
the supernatants were used for subsequent analyses. The cumulative
lysis during 1-h incubations usually was well below 10% of total cell
population. The values ofGSH in the medium were corrected for the
contribution by lysis, as before (4).
Assays. GSH in perfusates and incubation media (ECF) were mea-
sured by the recycling assay of Tietze (8). Whenever addition of other
compounds (i.e., organic anion dyes, bile acids and bilirubin in conju-
gated or unconjugated form) was made, we ascertained that their pres-
ence had no effect on determination of GSH values under our assay
conditions. Hepatic GSH was measured by the Owens and Belcher (9)
method, as described previously (3). Perfused liver homogenates, or
resuspended cell pellets were precipitated with 10% trichloroacetic acid
(1:1 vol/vol) and the supernatants were assayed for GSH. Glutathione
S-transferase was measured by the formation of the conjugate of 1-
chloro-2,4-dinitrobenzene-GSH conjugate, as before (3, 4).
Organic anion dyes were measured by direct spectrophotometric
assays after scanning for determination of their peak absorbance.
Thus, BSP and BSP-GSH conjugate (the latter prepared by the method
described by Whelan et al. [10]) were assayed at 580 nm (under alka-
line conditions), rose bengal at 550 nm, and indocyanine green at
800 nm.
Bilirubin solutions and HPLC analysis. All preparations, purifica-
tions, handling, and use in perfusions or incubations of UCB and
BMG were done under very dim lighting. Intermediate storage of
compounds was under total darkness at - 16'C. In addition, freshly
purified BMG and BDG were stored under 99.99% argon at - 16°C for
no longer than overnight, before use.
Fresh stock solution of UCB (5 mM in 100 mM Na2CO3) was
prepared, according to the method described by Paumgartner and
Reichen (1 1), just before use in perfusions or incubations. The stock
solution was then diluted to the desired concentration to obtain a
molar ratio ofUCB:bovine serum albumin of 1:1. Control incubations
with the highest concentration of Na2CO3 alone (without bilirubin),
used in our experiments, showed no effect on the GSH efflux or any
other parameter.
To obtain BMG, we used the preparative gradient HPLC method
described by Spivak and Carey (12). First, to obtain BMG- and BDG-
rich bile, we infused 50 Al/min of 1 mM UCB (diluted in 0.9% NaCl
from the 5 mM stock solution described above) i.v., through a jugular
catheter, into Sprague-Dawley rats and collected bile, in near darkness,
on ice, under a stream of 99.99% pure argon. Proteins of the bile
sample were denatured and precipitated by a 3:1, vol/vol, treatment
with HPLC-grade methanol. 1 ml ofthe supernatant was injected onto
a preparative column (Altex Ultrasphere-ODS, reverse phase, 5 Am, 10
mm ID X 25 cm L; Altex Scientific, Berkeley, CA) for separation by
the gradient method of Spivak and Carey (12) using a flow rate of 3.5
ml/min. The buffers used for HPLC were gassed with the high-purity
argon. BDG fraction eluted with a retention time of8-9 min and BMG
fraction with a retention time of 13-14 min. These fractions were
collected in three equal lots (- 5 ml each) and concentrated down (to
< 0.5 ml each) under a stream of high-purity argon at room tempera-
ture. The concentrated samples were subsequently desalted by Sep-Pak
C18 cartridges (Waters Associates, Milford, MA), with all steps carried
out using ice-cold, argon-gassed double-distilled water and HPLC-
grade methanol as follows. Each cartridge was wetted by 5 ml ofwater.
The concentrated sample was loaded onto the cartridge and washed
with 3 ml of water. Thereafter, BMG or BDG was eluted by 2-3 ml of
methanol. These desalted samples were evaporated down to near dry-
ness under a high-purity argon stream at room temperature and stored
overnight at -16'C. On the following morning, the specimens were
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taken to complete dryness to eliminate any traces of methanol. There-
after, BMG or BDG were resuspended at the desired concentration in
the incubation media containing bovine serum albumin just before the
addition of the hepatocytes, as described earlier.
To analyze the perfusate, or incubation media (ECF) samples, for
UCB, BMG, and BDG, a fivefold (vol/vol) dilution ofeach sample was
made with HPLC-grade methanol to precipitate the proteins, in prepa-
ration for loading the sample onto the analytical column. Cell-asso-
ciated bilirubin was extracted with 0.5 ml HPLC-grade methanol, as
stated before, and after centrifugation (5 s on a Microfuge), the super-
natant was injected onto the column. The analytical column was an
Altex Ultrasil-ODS, reverse-phase column (10 ,m, 4.6 mm ID X 25
cm L). The retention times with 1 m/min flow rate for the different
peaks were: BDG, 12.5 min; BMG, 17 min; and UCB, 25 min. With
our system, samples with concentrations as low as 1 MM were reliably
quantifiable using a l-ml injection of 1:5 methanol-precipitated sam-
ple and an absorbance scale of0.02 at 455 nm. Standards ofUCB were
run to quantitate all forms of bilirubin, based on the reported identity
of the extinction coefficients of the different moieties ( 13).
Results
Inhibition ofsinusoidal GSH effluxfrom the perfused liver
by BSP-GSH
We had previously reported the ability of - 10 MM of BSP-
GSH to inhibit (by 30%) the sinusoidal GSH efflux from the
isolated, perfused rat liver (3). In our present studies, we first
extended our observations over a range of BSP-GSH concen-
trations to establish whether there is a dose dependence be-
tween the inhibitor concentration and GSH efflux. In these
perfusions, after an initial control period, a 30-min step infu-
sion of BSP-GSH was given (data not shown; refer to Fig. 1
showing the design and data from similar studies using UCB).
About 15 min after the onset ofthe infusion, the declining rate
of GSH efflux reached a near plateau. Later, when the BSP-
GSH infusion was stopped, the efflux recovered in about 15
min to control (pre-BSP-GSH) levels. Thus, the inhibitory
effect of BSP-GSH was completely reversible. There were also
no adverse effects manifested throughout these perfusions as
evidenced by the 02 uptake values, which remained at typical
control levels (3); absence of breakdown of the liver, as moni-
tored by the release ofGSH S-transferase in the perfusates; and
steadiness of pressure throughout each perfusion.
We used the average value of the data points defining the
plateau value of inhibited efflux (15-30 min after onset of
infusion) to compute and express the inhibition ofGSH efflux
as the percentage ofthe mean control (uninhibited) efflux. The
results of a number of perfusions conducted with different
doses of BSP-GSH revealed a dose dependence between the
inhibition of GSH efflux and perfusate BSP-GSH concentra-
tion (Table I). The corresponding rates of uptake ofBSP-GSH
by livers were measured by the difference in the inflow-out-
flow concentrations of BSP-GSH in the perfusates during the
plateau phase of inhibition (Table I). The concentration of
BSP-GSH in the effluent perfusate fell to undetectable levels in
less than 2 min after the cessation of its infusion into the
perfusion line.
Effect ofbile acids and organic anion dyes on sinusoidal
GSH effluxfrom the perfused liver
Taurocholate, at the range ofconcentrations tested, i.e., 5-100
MM (n = 3), did not exert any inhibitory effect on the efflux of
Table . Inhibition ofGSH Effluxfrom the Perfused Rat Liver
by BSP-GSH**
Percfnt inhibition
Perfusate [BSP-GSHJ Rate of BSP-GSH uptake ofGSH efflux ril
IsM nmol/min * g liver
4.9±0.3 9.0±0.5 18.9±3.7' 4
10.0±0.7 11.1±0.8 28.5±2.7 1 1
31.7±1.1 20.0±4.7 49.6±2.2 5
Values given as mean±SEM.
* See text for details of design.
The livers were from normal, adlib-fed rats with 5.3 ± 0.4 umolGSH
per g liver.
I % Inhibition (from control efflux) was calculated using the mean of
data points in the 15-30 min period after the onset of BSP-GSH
infusion.
n, number of perfusions.
The rate of control (uninhibited) effilux for the total number of livers
used in this study was 15.2±0.9 nmol GSH/min * g liver.
GSH. On the other hand, all ofthe organic anion dyes tested in
two to three separate perfusions exerted potent inhibitory ef-
fects on the GSH efflux with 10-15 uM BSP exerting 30-50%
inhibition, 4 uM rose bengal inhibiting by 50%, and 1.5-2.0
;tM indocyanine green inhibiting by 40-45%. The inhibitory
effect of these three dyes was accompanied by toxic manifesta-
tions, such as declining 02 uptake, progressively increasing
pressure (resistance to flow) during the infusion ofthe dye, and
incomplete recovery ofthe GSH effilux to control levels follow-
ing the cessation of the infusion of these compounds (data not
shown).
Inhibition ofsinusoidal GSH effluxfrom the perfused liver
by bilirubin and the effect ofhepatic GSH concentration
Since bilirubin is a physiologically relevant and important or-
ganic anion, we were interested in determining if, in the range
of normal plasma concentrations ofUCB (< 20 IAM), it would
exert any inhibitory effect on the GSH efflux from the perfused
liver. UCB caused an inhibition of the GSH efflux which was
not accompanied by the toxic manifestations observed with
the dyes. In fact, it was possible to conduct perfusions with two
successive and increasing doses of UCB on the same liver, a
sample of which is presented in Fig. 1. As can be seen, after
each step infusion of UCB, the GSH efflux arrived at a near
plateau in 15 min, after the onset of each respective dose of
infusion.
A group of perfusions was done on livers with normal he-
patic GSH levels, as well as a group with elevated hepatic GSH
levels (CoCl2-induced) to determine if raising intracellular
GSH would overcome the inhibitory effect of UCB (presum-
ably by competition for the carrier). As seen in Table II, there
was a dose-dependent inhibition of GSH efflux. In addition,
significantly less inhibition of GSH efflux was observed in
livers with elevated GSH compared to the livers with normal
GSH. The rate of uptake of UCB increased with increasing
concentrations in the perfusate, but was indistinguishable be-
tween normal and CoCl2-treated groups. Normal and CoCl2-
treated livers had indistinguishable GSH effluxes due to both
values being near saturation levels (pooled value of efflux
shown in the footnote to Table II). Thus, apparently, elevated
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Figure 1. Sample perfusion with bilirubin. Results from perfusion of
one liver with two successively increasing doses of UCB, i.e., 10 and
20 AM, are shown. Shaded areas highlight the duration of perfusion
for each dose. 02 uptake at the end of each interval is shown on top.
hepatic GSH did not overcome inhibition by a greater absolute
rate of efflux of GSH, or a decreased rate of uptake of UCB.
Kinetics ofthe inhibition by bilirubin ofGSH effluxfrom
freshly isolated hepatocytes and the effect ofcellular
GSH concentration
To extend our findings with UCB in the perfused liver, and to
study the kinetics and characteristics of inhibition in more
detail, we turned to the isolated cell system. The results from a
sample experiment are shown in Fig. 2, which also presents the
design of these incubation experiments. As before (4, 14), the
appearance of GSH in the incubation medium (referred to as
ECF) was nearly linear and accompanied by a concurrent drop
in the cellular GSH, such that the total (cells + ECF) GSH
remained near-constant, or decreased slightly, in 30-60-min
incubations. Thus, as before (4, 14), these hepatocytes were
Table I. Inhibition ofGSH Effluxfrom Rat Livers
Perfused with UCB*
Percent inhibition
ofGSH effluxt
Perfusate [UCB] Rate ofUCB uptake Nonnal CoCI2-treated n
ElM nmol/min * g liver
5.8 9.4 7.0 1
11.1, 12.6 28,28 28,42 2
21.0±1.5 37.9±1.9 59.9±2.7 7
2 1.0±0.9 37.3±6.9 - 43.7±0.9§ 3
* Liver GSH values were 6.0±0.2 (mean±SEM, n = 10) and
1.1±0.6 (n = 3) Amol/g liver for normal and CoC12-treated groups,
respectively.
* The rate of control (uninhibited) effilux for the normal vs. CoCl2-
treated groups were similar and their pooled value was 15.4±0.6
nmol GSH/min * g liver. The percent inhibition (from control efflux)
was calculated using the data from the 1 5-30-min period after the
onset of bilirubin perfusion.
§ The mean percent inhibition for CoCl2-treated group (i.e., 43.7) was
significantly lower (P < 0.01, unpaired t test) than the corresponding
normal group (i.e., 59.9) perfused with the same concentration of
UCB.
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Figure 2. Sample incu-
bations of hepatocytes
showing the dose-de-
pendent inhibitory ef-
I-''' fect ofUCB added to
the incubation medium.
(o) Control (no UCB);
^,_ (9) 1 MM UCB; (A) 5
uM UCB. The rates of
control and inhibited
efflux were calculated
(linear regression) from
> > the slope of the accu-
mulation of ECF GSH
(upper panel). The inhi-
bition of GSH efflux is
not due to depleted cel-
o lular GSH (middle
panel). As before (4),
the hepatocytes were
not synthesizing any
GSH de novo, such that
, > the sum of ECF and
cell GSH did not rise
0 20 40 60 during the incubations
MINUTES (lower panel).
not synthesizing any net amount ofGSH de novo during our
incubations, and the decline of cellular GSH was almost quan-
titatively accounted for by the loss due to efflux. The rate of
efflux in each incubation was estimated with the slope of the
linear regression fit to the ECF GSH data, as shown in Fig. 2.
As can be seen, doses as low as 1 and 5 MM ECF UCB were
capable of inhibiting the GSH efflux in comparison to control.
We have verified that the fall in the rate ofGSH efflux due to
UCB was not accompanied by a fall in the cellular ATP levels
(Fernandez-Checa et al., manuscript submitted for publica-
tion) or generally reduced transport functions, as checked with
["4C]glycine uptake (data not shown).
Fig. 3 presents the bilirubin data from a group of incuba-
tion experiments with 20 AM ECF UCB. Shortly after the
suspension of hepatocytes in the medium containing 20 M
UCB (- 2 min to the onset of t = 0 for our kinetic measure-
ments), there was a considerable initial drop (- 25%) in the
ECF UCB. This drop was present, even at 4VC incubation and
in ECF samples taken as quickly as it was feasible, i.e., a few
seconds, after the suspension of cells. However, whereas in
370C incubations there was a further continuous decline in the
ECF UCB to concentrations below 10 AM at 60 min, there was
no further fall in the 4VC incubations. Cell-free control incu-
bations conducted in parallel at 370C showed no spontaneous
decline of ECF UCB; thus, post zero-time disappearance of
ECF UCB was caused by the presence of cells due to continued
binding/uptake of UCB. Cell UCB values (Fig. 3) showed the
presence of a large early component, correlated with the initial
rapid fall observed in the ECF UCB. This high, near-instanta-
neous, cell-associated value is probably due to the binding of
bilirubin to the cell surface and exterior of the plasma mem-
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brane of hepatocytes. Thus, the cell-associated UCI values at
any time point represent a combination of a large membrane-
bound component and the intracellular UCB. Therefore, at
any given time point, it is not possible to accurately determine
the fraction of cell-associated UCB that is truly intracellular.
Whereas cell UCB. accumulated to a constant level in 4VC
incubations, in 370C incubations it reached an early peak and
subsequently declined. The additional decline was presumably
due to conjugation and metabolism of UCB to BMG (and
BDG) as shown in Fig. 3. Cell BMG also rose to a peak and
declined in 370C incubations, while it remained undetectable
in 4VC incubations, consistent with the apparent lack of me-
tabolism manifested by the ECF and cell UCB data. The desti-
nation ofdeclining cell BMG was not known, since the appear-
A 370C, no cells
* 370C, 10'cells/ml
040C, 10cells/ml
21<
1.II
-20 20 40 60
MINUTES
Figure 3. The fate of bilirubin in incubations with hepatocytes from
Sprague-Dawley rats. UCB was added to the incubation media
(ECF) containing equimolar bovine serum albumin. Thereafter, he-
patocytes were rapidly dispersed in ECF. There was a precipitous ini-
tial fall in ECF UCB after suspension of hepatocytes as observed by
the zero time sample, identified by vertical dashed line, taken - 2
min after cell dispersion. This fall, which was present in ECF sam-
ples taken as rapidly as possible (few seconds) after dispersing the
cells, represents a large binding component of UCB to the cell
plasma membranes. This early component that is observed also in
the cell UCB data was present even at 4VC incubations (o). However,
only at 370C incubations (- with bars, representing mean±SEM of n
= 3-8 incubations), the fall in the ECF UCB continued beyond the
zero time, and was accompanied by the concurrent appearance and
metabolism of cell UCB to BMG (and BDG, not shown). The up-
take and metabolism at 4VC incubations were absent after the initial
binding phase. There was no spontaneous fall in ECF UCB in cell-
free incubations (A, n = 1-3).
ance ofcell BDG could not account for it (data not shown) and
the amount of BMG or BDG released to the medium was
below detection levels which precluded their accurate estima-
tion. Thus, - 15% and - 25% of the total bilirubin added at
the beginning ofeach incubation could not be accounted for at
30 and 60 min, respectively. We do not know whether progres-
sive binding of bilirubin to membranes with subsequent diffi-
culty of extraction contributes to poorer recoveries, or not.
A number of cell incubations were done as above, at 370C
and in the presence of different initial concentrations of ECF
UCB, to define the kinetics of inhibition by UCB of GSH
efflux. These studies were done with hepatocytes from normal,
ad lib-fed rats, as well as those from rats treated with CoCl2, to
raise their hepatocellular GSH. The results are summarized in
Fig. 4. The data for inhibited GSH effilux, expressed as the
percentage of control, clearly defined a dose-dependent rela-
tionship between the degree of inhibition and the initial ECF
concentration of the inhibitor. In addition, as was the case in
the perfused liver studies, the inhibition was partially over-
come by increased cellular GSH concentration. However,
changes in cellular GSH were not accompanied by changes in
the uptake ofUCB as measured by the extracellular disappear-
ance and cellular appearance (data not shown). Since raising
GSH overcame the inhibition, it appeared that UCB competi-
tively inhibited GSH transport.
General characteristics ofthe inhibition by bilirubin of
GSH effluxfrom isolated hepatocytes
Up to this point, we had observed the inhibitory effect ofUCB
after its addition to the incubation medium. Since UCB is
taken up by the hepatocytes and conjugated to the
mono-(BMG) as well as diglucuronide (BDG) forms, two
other important questions remained to be explored. These
were: (a) Does bilirubin have to be taken up to exert its inhibi-
tory effect from inside the cell? (b) If so, is it the unconjugated
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Figure 4. Kinetics of inhibition ofGSH efflux from Sprague-Dawley
hepatocytes in response to the addition of UCB to the incubation
medium and the effect of cellular GSH. The data (mean±SEM, n
= 3-4), expressed in units of GSH efflux as percentage of control, or
uninhibited efflux, show a dose-dependent relationship between the
initial ECF concentration of UCB and the magnitude of inhibition.
Raising the cellular GSH concentration, denoted as [GSH]j, from a
mean of 3.8 to 6.9 mM caused the inhibition to be overcome par-
tially. This effect was not due to changes in UCB uptake (not
shown), or increased GSH efflux (since both cell GSH concentrations
are associated with comparable efflux rates, pooled value
= 0.180±0.015 nmol GSH/min per 106 bells, due to being near or at
saturation [3, 4]). The continuous curves are the result of a model-
fitting exercise presented in the Discussion.
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(UCB) or conjugated (BMG and BDG) form of bilirubin that
inhibits GSH efflux? To attempt to answer the above two ques-
tions dealing with the issues of sidedness and molecular form,
we did the following experiments.
Sidedness. Evidence that UCB had to be taken up by the
hepatocyte in order to inhibit the cellular GSH efflux was
obtained with the following approach. Wolkoffet al. (15) have
shown that the uptake oforganic anions, including bilirubin, is
dependent on the presence of Cl- ions in the incubation
media, or perfusates, in short-term rat hepatocyte cultures, or
perfused livers. Taking advantage of this observation, we in-
cubated freshly isolated hepatocytes in the presence and ab-
sence of UCB in Krebs-Hepes (control) and Cl--free (sucrose-
Hepes) media (see Methods). Table III shows the summary of
the results from cell incubation experiments. Identical cellular
GSH effluxes occurred in Krebs and Cl--free media, in the
absence of UCB. However, when UCB was present, only the
GSH efflux from cells in Krebs media was inhibited. No inhi-
bition ofthe GSH efflux was observed in the Cl--free medium.
Experiments with perfused livers corroborated these findings,
i.e., no inhibitory effect ofUCB was observed when livers were
perfused with 10-20 ,uM UCB with Cl--free medium (data not
shown). It should also be noted that the initial cell surface
binding in Cl--free medium and Krebs media were identical
(not shown). However, the progressive decline in medium
UCB and appearance of cellular BMG were not observed in
the Cl--free medium. This also indicates that surface binding
alone does not inhibit GSH efflux.
An additional study was conducted to determine whether
the loading and unloading of hepatocytes with UCB would
show a clear-cut relationship to GSH efflux. Thus, hepatocytes
were preincubated in Krebs medium with and without 20 ,M
UCB for 30 min, as before. However, subsequently, they were
washed and resuspended in Krebs media with 0.1% and 5%
bovine serum albumin for 20 min. This was done to remove
cellular UCB with the high concentration of acceptor albumin
in the medium. Afterwards, cells were washed again, resus-
pended in Krebs buffer, and incubated for 30 min to deter-
mine the rate of GSH efflux. After incubation with 5% albu-
min, no UCB remained in the cells whereas 0.1% albumin was
ineffective in removing cellular bilirubin. Table IV shows the
summary of the results from these experiments. As can be
seen, the GSH efflux from cells incubated with 5% albumin
recovered to levels indistinguishable from control. However,
cells resuspended in albumin-free medium, retained an inhib-
ited level of GSH efflux (i.e., 41% of control) in the total ab-
sence of any extracellular UCB. This degree of inhibition was
close to the original level of inhibition measured in the pres-
ence of 20 ,uM extracellular UCB (i.e., 44% of control).
Molecular form. To delineate whether it is the unconju-
gated or the conjugated form ofbilirubin that is responsible for
inhibition ofGSH efflux, we did the following set of studies.
To clarify whether UCB alone can exert an inhibitory ef-
fect, we used hepatocytes obtained from Gunn rats. Hetero-
and homozygote Gunn rat hepatocytes were incubated in the
same way as those from Sprague-Dawley rats, described above.
Table V presents the results of these experiments. In both
groups of cells (homozygote and heterozygote) addition of
UCB caused the inhibition (dose-dependent) of GSH efflux
from hepatocytes. However, while heterozygote cells were
producing BMG and BDG during the incubation, there were
no detectable traces of BMG (and BDG) in the cells from
homozygote Gunn rats (not shown). Thus, it was clear that
UCB alone, without being converted to BMG and BDG, could
inhibit the GSH effilux.
After delineation ofthis point, the possibility still remained
that BMG and BDG were also capable of inhibiting the GSH
efflux. Therefore, we performed a group of experiments using
BMG and BDG purified by the preparative HPLC method of
Spivak and Carey (12), as described in Methods. The effect of
BMG was studied more extensively than the BDG in an at-
tempt to define its kinetics of inhibition. The disappearance of
ECF BMG in 1-h incubations was similar to that observed
with UCB in cells from Sprague-Dawley and Gunn rats (not
shown), with negligible spontaneous disappearance of ECF
BMG in cell-free incubations. Also the main difference from
UCB data was that the initial, rapid fall ofECF BMG was only
a small fraction of that of UCB. The fractional inhibition of
GSH efflux by BMG was indistinguishable among the differ-
ent cell types, i.e., Sprague-Dawley, heterozygote and homo-
zygote Gunn rats. Hence, the data showing the inhibitory ki-
netics for all cell types have been pooled and presented in Fig.
5. As can be seen, there was a dose-dependent inhibition of
GSH efflux by BMG, similar to that observed with UCB.
The effect ofBDG was verified only for initial ECF BDG of
2.21±0.2 uM in 5 cell preparations and found to decrease the
hepatocellular GSH efflux to 57.2±6.3% of control (uninhi-
bited) efflux.
Discussion
Using isolated, in situ, single-pass rat liver perfusions and
freshly isolated hepatocyte incubations, we have reported es-
sentially identical kinetics of sinusoidal GSH effilux as a func-
Table III. Effect ofUCB in Cl--free (Sucrose-Hepes) Medium on GSH Effluxfrom Isolated Hepatocytes
Cellular [GSH]
Incubation
(n = 3) 0 min 60 min GSH efflux GSH efflux P*
nmol/J0t cells nmol/min per 106 cells % control
Krebs-Hepes 38.8±1.1t 28.5±8.6 0.180±0.05 100
Sucrose-Hepes 35.8±1.2 22.2±4.1 0.190±0.06 106 NS
20 ALM BR in Krebs-Hepes 40.7±4.0 33.6±5.4 0.062±0.03 34 <0.01
20 AiM BR in sucrose-Hepes 38.5±1.4 23.4±4.9 0.179±0.06 99 NS
* P values, from unpaired t tests, are for the GSH efflux in comparison to Krebs-Hepes control. t Mean+SD, n = 3.
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Table IV. Effect ofBilirubin Loading and Unloading ofHepatocytes on GSH Efflux*
Cellular [GSHJ
Incubation 0 min 30 min GSH Efflux Cellular UCB GSH efflux Pt
nmol/l06 cells nmol/min per 106 cells nmol/J06 cells % control
During loading
Control 54.0±l.0 39.2±0.5 0.223±0.021 100
20 AM UCB 53.0±0.9 48.2±2.0 0.099±0.021 4.2±0.7 44 <0.005
After unloading
Control 29.7±1.1 27.6±2.7 0.207±0.040 100
0.1% BSA 31.8±2.2 27.4±3.6 0.085±0.012 3.6±0.3 41 <0.01
5% BSA 27.3±0.5 25.9±0.4 0.174±0.030 <0.1 84 N.S.
* Hepatocytes were preincubated with and without 20 ,M UCB for 30 min to load some of the cells with bilirubin, while measuring their GSH
efflux. Subsequently, these preincubated cells (both control and UCB-incubated) were washed and suspended in media containing 0.1% and 5%
BSA for an additional 20 min. Finally, the cells were washed again and resuspended in Krebs-Hepes medium with no extracellular UCB, or
BSA, to measure their GSH efflux over a 30-min interval (after unloading, above). Separate measurements established that the incubation of
hepatocytes in 5% BSA alone does not affect the rate ofGSH efflux after the cells are washed of BSA (data not shown). t P values, from un-
paired t tests, are for the GSH efflux in comparison to control for each set of data. § Mean±SD, n = 3.
tion of hepatocellular GSH concentration in both systems (3,
4). The kinetics of efflux was characterized by a sigmoidal-sat-
urable shape, which could not be fitted by the Michaelis-Men-
ten model. The Hill equation was used, chiefly as a utilitarian
model, to fit the data from perfused livers and isolated hepa-
tocyte studies to extract the Vm.. (20-26 nmol . min' g-')
and Km (3.2-3.6 gmol/g or mM) values for the transport ki-
netics. A value of n - 3 was required as the number ofcooper-
ative binding/transport sites in the Hill model to obtain the
best fits (3, 4). Thus, the saturability of the transport rate im-
plicated the possible involvement of a carrier mechanism.
However, saturability is a necessary, but not a sufficient crite-
rion for carrier-mediated processes. Two additional qualifying
criteria were verified and met subsequently. One, i.e. trans-
stimulation, was demonstrated in the sinusoidal membrane-
enriched vesicle model (6). The other, the ability of other but
similar molecules to compete with and inhibit the transport of
GSH, was confirmed with BSP-GSH in our preliminary
work (3).
Table V. Effect ofUCB on the GSH Efflux
from Gunn Rat Hepatocytes*
Initial ECF [UCB] Cell BMG GSH efflux
ILAN % control
Heterozygote 20.1±1.1 (4)t + 39.9±3.7
Homozygote 4.3 - 82.1
8.5 - 64.3
20.4±1.6 (3) - 50.4±5.6§
* The hepatocytes used in these studies had 42.2±2.9 nmol GSH/10
cells and a control (uninhibited) efflux of 0.172±0.029 nmol GSH/
min per 106 cells (n = 11, preparations from four heterozygote and
three homozygote Gunn rats).
tMean±SEM (n).
Not significantly different from the corresponding value for the het-
erozygote group.
In our present work, we have attempted to explore the
generality of the inhibitory phenomenon by extending our ob-
servations to other organic anions. We have found that a bile
acid transported by a carrier mechanism, i.e., taurocholate
(studied up to 100 MM), had no effect on the sinusoidal GSH
efflux from the perfused liver. In contrast, all of the organic
anions screened, i.e., BSP, rose bengal, indocyanine green, and
UCB, at rather low concentrations, i.e., 2-20 ,M, were able to
inhibit the sinusoidal GSH efflux from the perfused rat liver.
However, the effect of all ofthe tested organic anions, with the
exception of UCB, was accompanied by toxic manifestations,
i.e., declining hepatic 02 uptake, increasing perfusion pressure
(resistance to flow), and incomplete recovery ofGSH efflux to
pre-organic anion infusion (control or uninhibited) values.
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Figure 5. Kinetics of inhibition ofGSH efflux by BMG. No differ-
ences were observed among the hepatocytes from Sprague-Dawley,
heterozygote and homozygote Gunn rat cells; therefore, the data
(mean±SEM, n = 3-8) were pooled for presentation. The inhibition,
similar to the incubations with UCB, was dose-dependent. Cellular
GSH concentrations were also indistinguishable between the differ-
ent groups, pooled value = 39.2±2.5 (n = 25). The continuous curve
represents the result of the model-fitting exercise presented in the
Discussion.
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Since bilirubin is a physiologically relevant and important
organic anion, we extended our study of its detailed kinetics of
inhibition of GSH effilux using the freshly isolated hepatocyte
system. Incubations of the hepatocytes with physiological cir-
culating levels ofUCB, i.e., . 20 1AM, resulted in potent, dose-
dependent inhibitory effects (up to - 70% inhibition) that
could be partially overcome by raising the cellular GSH con-
centrations. (Note: We do not know whether the mechanism
by which the cellular GSH is raised will have effects on the
outcome of our studies. CoCl2 treatment does not affect the
magnitude of sinusoidal GSH efflux, which remains at maxi-
mal saturation levels. Thus, it presumably increases the he-
patic GSH pool size by increasing the synthetic rate.) We also
ruled out the possibility that falling cellular ATP levels were
the cause of falling GSH efflux in response to UCB, and veri-
fied that UCB had no effect on the uptake of ['4Clglycine
during our incubations (up to 1 h). Thus, these observations
were consistent with the view ofUCB competitively inhibiting
the GSH carrier. It should be noted that in isolated cells an
uncertain but significant portion of the GSH efflux could rep-
resent the canalicular equivalent. Substantial canalicular GSH
efflux occurs in the intact liver (16), and some organic anions
can inhibit this component (17). BSP-GSH does not affect
canalicular GSH transport (17, 18). However, the effects of
UCB and glucuronides have not been examined. Therefore,
the effects of bilirubin on GSH efflux, although inhibiting the
sinusoidal component in the perfused liver, might also influ-
ence the "canalicular" component in the isolated cells. Our
studies cannot resolve this uncertainty, although we can be
certain that a significant component of the inhibitory effect of
UCB is due to its action on the sinusoidal component.
In our efforts to establish the sidedness of inhibition, we set
out to delineate whether UCB had to be taken up, before it
could exert an inhibitory effect on the GSH efflux. The une-
quivocal demonstration of the inhibitory effect of bilirubin on
GSH efflux being from inside the cell was made by taking
advantage of an observation reported by Wolkoff et al. (16).
Their work showed that the hepatic uptake of organic anions,
including bilirubin, is dependent on the presence of extracel-
lular Cl- and drops to zero values when Cl-' is absent in the
media incubating hepatocytes or perfusing livers. Using Cl-'-
free buffer, made by replacing NaCl and KCl with equimolar
sucrose in the Krebs buffer, we were able to show the total
absence of the effect of UCB on GSH efflux from isolated
hepatocytes and perfused livers. Not only could we show that
uptake was necessary for inhibition but reversibility of the
inhibitory effect required complete removal ofthe cellular bili-
rubin.
Another complication was the fact that UCB taken up by
hepatocytes was rapidly conjugated to BMG and BDG. Thus,
we could not be sure which molecular form was responsible for
the inhibition of GSH effilux from inside the cell. The use of
UCB and homozygote Gunn rat cells, that are incapable of
producing BMG and BOG, unequivocally proved that the un-
conjugated form of bilirubin can inhibit the GSH efflux. On
the other hand, when purified BMG and BDG were used, they
too were taken up and inhibited GSH efflux from isolated
Sprague-Dawley, heterozygote and homozygote Gunn rat he-
patocytes. Thus, it appears that UCB, BMG, and BOG are
each capable of inhibiting the effiux ofGSH from hepatocytes.
The similar potency of their effects, i.e., the degree of inhibi-
tion in relation to the extracellular concentrations of inhibitor
used, precludes explaining the effect of BMG (and BDG) as
due to deconjugation of the diglucuronide form to UCB (19).
In our experiments, the inhibitory effect of the conjugated
forms of bilirubin took place in the absence of detectable cel-
lular levels of UCB. Thus, it seems doubtful that sufficient
UCB could have been generated to explain the potency of the
effects we observed with the conjugated forms of bilirubin.
Our kinetic data cannot be readily modeled to distinguish
the exact nature of the inhibition and/or the accurate value of
the kinetic parameters of inhibition, such as K,. This is because
we are not able to identify and measure the size of the intra-
cellular pool(s) of the inhibitor that exerts an effect on the
GSH effilux. With a simplifying assumption, it is possible to fit
a purely competitive kinetic model to the data representing the
% inhibition of GSH efflux vs. extracellular UCB or BMG
concentration. The simplifying assumption is that, in the
ranges ofKm of inhibitor uptake, at which we have been work-
ing (20, 21), there might be a not-too-far from linear and one-
to-one, dose-dependent relationship between the ECF and cel-
lular concentrations of the inhibitor(s). Then, the Hill model
that we have used to fit the kinetics of the uninhibited GSH
efflux (3) can be expanded with a purely competitive inhibi-
tory term, as presented before (14), to fit our present data for
UCB and BMG incubations. The outcome of such fits, using
the SAAM program (22), are shown by the curves in Figs. 4
and 5. Interestingly, the kinetic data from cells with elevated
GSH can be simultaneously and consistently fitted along with
that from the cells with normal GSH, using a single SAAM run
(using the interrupt feature). Thus, with fairly stringent criteria
for fitting the data with no more than two adjustable parame-
ters, i.e., Kj and n (number of inhibitor sites) (14), good fits are
obtained. The Kj values extracted by our fitting exercises were
1.1±0.10 and 0.54±0.13 ,gM (mean±SD) for ECF UCB and
BMG data, respectively. However, these ought to be regarded
as "apparent" or fictitious Ki values only, and the magnitude
of the true K1 values could be quite different from these. In
both UCB and BMG experiments, the value of n, the number
of cooperative inhibitor sites per carrier unit, did not exceed 1,
implying the involvement of only a single inhibitor site.
In conclusion, we have shown that organic anions, but not
bile acids, when added to the perfusion or incubation media,
can inhibit the sinusoidal effilux of GSH from the perfused
liver and isolated hepatocytes. Bilirubin at circulating plasma
levels is capable ofinhibiting the hepatic GSH effilux. All forms
of bilirubin, i.e., UCB, BMG, and BDG are able to inhibit the
efflux, and the inhibitory effect is exerted from inside the he-
patocyte. These findings are not in conffict and, in fact, are
consistent with the present knowledge and our working hy-
pothesis of hepatic GSH efflux. Thus, organic anions enter the
hepatocyte via a carrier(s), which is (are) distinct from the
GSH carrier, but, once in the cell, compete with and inhibit
the GSH carrier. On the other hand, the cellular GSH level has
no effect on the uptake of bilirubin, but the apparent competi-
tive inhibition by bilirubin of GSH efflux can be partially
overcome by raising the cellular GSH concentration. It re-
mains to be determined whether the efflux of organic anions is
actually mediated by the GSH carrier.
Finally, our findings with respect to the effect of bilirubin
on hepatic sinusoidal GSH efflux might have pathophysiologi-
cal and clinical significance. Since the liver contributes > 90%
of plasma GSH (2), during pathological states of hyperbiliru-
binemia, such as jaundice, it is possible that the efflux of he-
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patic GSH to the blood might be inhibited to the extent that
can cause a drop in the circulating GSH. This outcome could
have deleterious effects on the whole organism's capacity for
defense against xenobiotics and radical oxygen products, and,
thus, give rise to further complications. On the other hand, the
body may compensate by elevated hepatic GSH levels to over-
come the inhibition and maintain normal levels of hepatic
sinusoidal GSH efflux. These questions remain to be explored.
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